concentration of biomaterials: virus concentration and viral protein isolation.

NLM AIDSLINE Concentration of biomaterials: virus concentration and viral protein isolation. Hammar L; Department of Veterinary Virology, Biomedical Center,
November 30, 1994

Methods Enzymol. 1994;228:640-58. Unique Identifier : AIDSLINE Animal Biotechnology/INSTRUMENTATION/METHODS Cell Line Chromatography, Gel/METHODS Dextran Sulfate Encephalitis Virus, Venezuelan Equine/ISOLATION & PURIF Enzyme-Linked Immunosorbent Assay Human HIV-1/ISOLATION & PURIF HIV-2/ISOLATION & PURIF Indicators and Reagents Measles Virus/ISOLATION & PURIF Polyethylene Glycols Retroviridae/ISOLATION & PURIF Support, Non-U.S. Gov't SIV/ISOLATION & PURIF Viral Proteins/ISOLATION & PURIF Virology/INSTRUMENTATION/METHODS Viruses/ISOLATION & PURIF Water Microbiology JOURNAL ARTICLE

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 COLORADO: Boulder Groups Honor More Than 150 Local AIDS Victims PENNSYLVANIA: Area Residents Screened for Hepatitis C on Sunday COLORADO: Peer to Peer: Teens Work to Educate Peers on Pregnancy, STDs at CCHS OREGON: Portland Barefoot 3 x 3 Benefit Tournament to Draw Hundreds to Northeast Portland TEXAS: Temple - Wellness and Sexual Health Classes Helping Kids to Abstain CONNECTICUT: Yale Researchers Urge More Street Work When Studying People With Both HIV, Hepatitis C JAMAICA: AIDS Awareness Workshop Organised for High-School Students EUROPE: EU Issues Stringent Sharps Regulations CALIFORNIA: $50,000 Prisoner Prescription: Inmates Get Expensive Hepatitis C Treatment Tentative approval of lamivudine and tenofovir disoproxil fumarate Tablets, 300 mg/300 mg Sangamo BioSciences Presents New Data From In Vivo Protein Replacement Platform For Development Of ZFP Therapeutics® For Monogenic Diseases ALABAMA: Alabamians at Risk Are Urged to Learn More About Viral Hepatitis UNITED KINGDOM Elevated Prevalence of HIV and Viral Hepatitis in Men Injecting Anabolic Steroids Hepatitis C: Closing in on its viral origins Boehringer Ingelheim's Faldaprevir-Based Treatment Regimen Achieved Viral Cure in up to 80 Percent of Patients with Hepatitis C in Phase 3 Pivotal Trial More than 60 dental patients test positive for viruses HIV concentrations in breast milk higher at earlier, abrupt weaning BELGIUM: Long-Term Suppression of Viral Load and Sustained CD4 Cell Increase Reduce Risk of Cervical HPV Infection for HIV-Positive Women Agency Reviews Patent Application Approval Request for "Methods for Treatment of HIV and Other Infections Using a T Cell Or Viral Activator and Anti-Retroviral Combination Therapy"MASSACHUSETTS: Mass. Looks Into Risk of Virus at BMC
Information in this article was accurate in November 30, 1994. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.